# European Union Registry in Paediatric Chronic Kidney Disease Patients Looking at Safety and Usage Patterns of Darbepoetin Alfa

> **NCT00838097** · — · COMPLETED · sponsor: **Amgen** · enrollment: 321 (actual)

## Conditions studied

- Chronic Kidney Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00838097
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2013-02
- **Final completion:** 2013-02
- **Target enrollment:** 321 (ACTUAL)
- **Last updated:** 2014-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00838097

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00838097, "European Union Registry in Paediatric Chronic Kidney Disease Patients Looking at Safety and Usage Patterns of Darbepoetin Alfa". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00838097. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*